肺心病高凝状态早期诊断与干预的临床研究  

The clinical meaning with early diagnosis and intervention of hypercoagulable states of chronic pulmonary heart disease

作　　者：朱鹏程 黄楚泉 林振发 Zhu Pengcheng Huang Chuquan Lin Zhenfa

机构地区：广东省饶平县华侨医院,515700

出　　处：《中外健康文摘：临床医师》2008年第1期25-26,共2页

摘　　要：目的：针对肺心病高凝状态的早期诊断和临床干预进行观察分析,旨在认识肺心病高凝状态早期诊治的临床意义。方法：本组病例82例,随机分为治疗组（40例）和对照组（42例）,两组患者年龄,性别,病情无显著差异,在确诊肺心病早期高凝状态后,治疗组在对照组治疗的基础上加用葛根素注射剂和低分子肝素。结果：治疗组治疗前后高凝状态血液指标改善程度及疗效结果与对照组比较有明显差异（P〈0.05）。结论：葛根素联合低分子肝素治疗肺心病早期高凝状态是安全有效的。Objective：To analyse early diagnosis and clinical intervention with hypercoagulable states of chronic pulmonary heart disease, and knowing the clinical meaning with their. Method： This case 66 examples is divided into the treatment set （40 examples） and the antitheses set （42examples）, two sets of sufferers age, sexes, the condition didn＇t show markedly difference, the treatment set added to use the Gegensu injection and low mark sub-heparin in the antitheses set of foundation after diagnosing hypercoagulable states of Chronic pulmonary heart disease. Result：After the treatment set was treated, improvement degree with blood index of hypercoagulable states and curative effect have obvious difference companing the antitheses set. Conclusion： That Gegensu injection and low mark sub-heparin treat early hypercoagulable states of chronic pulmonary heart disease is safe and effective.

关 键 词：肺心病 高凝状态 葛根素 低分子肝素 

分 类 号：R256.19[医药卫生—中医内科学;医药卫生—中医学]